Vol 2003, No 39 (2003)

Table of Contents

Research & Development

Aventis and ImmunoGen Enter Anticancer Antibody Collaboration Abstract pdf
Business Review Editor

Licensing

Boehringer Licenses Medivir’s MIV-310 Antiviral Drug Abstract pdf
Business Review Editor
Pozen and Nycomed Enter into Option Agreement for NSAID Lornoxicam Abstract pdf
Business Review Editor

General

Millennium, J&J and Velcade Abstract
Business Review Editor
Quid Pro Quo Deals Abstract
Business Review Editor
Therapy Focus: Migraine Abstract
Business Review Editor

Mergers & Acquisitions

Roche Acquires Cardion’s IL-15 Antagonist Abstract pdf
Business Review Editor
Genzyme Expands Immunology Portfolio Through Sangstat Acquisition Abstract pdf
Business Review Editor

Company Profile

Epigenomics AG Abstract pdf
Business Review Editor
GPC Biotech AG Abstract pdf
Business Review Editor

Distribution & Marketing

SkyePharma License Marketing and Distribution Rights for DepoCyte® to Mundipharma Abstract pdf
Business Review Editor


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.